Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation

Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced the results of a clinical study showing that an iCALM™ attenuated allergen-induced bronchitis in susceptible asthmatic patients.

Common antibiotic boosts death risk: study

A popular antibiotic used for treating bronchitis, pneumonia, ear infections and sexually transmitted diseases may boost the risk of death, a US study said Wednesday.

Popular Antibiotic May Be Responsible For Sudden Cardiac Death

Lawrence LeBlond for RedOrbit.com Azithromycin, a common antibiotic used for treatment of bronchitis, pneumonia, and sexually transmitted diseases (STDs), appears to also boost the risk of sudden cardiac death when compared with no antibiotic treatment, according to a US study on Wednesday. Azithromycin has been available worldwide since the 1980s, but the new study, published in the New England ...

Z-pack antibiotic poses 2.5-fold higher risk of cardiovascular death

An antibiotic that is widely prescribed in India to combat bacterial sinus infections and bronchitis has been found to be bad for heart.

Antibiotic linked with rare but deadly heart risk

An antibiotic widely used for bronchitis and other common infections seems to increase chances for sudden deadly heart problems, a rare but surprising risk found in a 14-year study.